Violet Kasabri (V Kasabri)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Topics

Lipopolysaccharide Induced

Binding Protein

Metabolic Syndrome

Top Venues

Asian Pacific journal of cancer prevention : APJCP

Hormone molecular biology and clinical investigation

Therapeutic advances in endocrinology and metabolism

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Hiba Al Fahmawi, Abla Albsoul-Younes, Mohammad I Saleh, Mahmoud Abu Abeeleh, Violet Kasabri
Drug Therapy Problems Identified by Clinical Pharmacists at a General Surgery Ward of an Academic Referral Hospital in Jordan. Therapeutics and clinical risk management 20 (2024)
Razan Ibrahim, Violet Kasabri, Suhair Sunoqrot, Dana Shalabi, Rema Alkhateeb, Yusuf Alhiari
Preparation and Characterization of Rutin-Encapsulated Polymeric Micelles and Studies of Synergism with Bioactive Benzoic Acids and Triazolofluoroquinolones as Anticancer Nanomedicines. Asian Pacific journal of cancer prevention : APJCP 24 (3) (2023)
Razan Ibrahim, Violet Kasabri, Suhair Sunoqrot, Dana Shalabi, Rema Alkhateeb, Yusuf Alhiari
Preparation and Characterization of Rutin-Encapsulated Polymeric Micelles and Studies of Synergism with Bioactive Benzoic Acids and Triazolofluoroquinolones as Anticancer Nanomedicines. Asian Pacific journal of cancer prevention : APJCP 24 (3) (2023)
Esraa Qashou, Yusuf Al-Hiari, Violet Kasabri, Rabab AlBashiti, Sundus AlAlawi, Ahmad Telfah, Amani AlHadid
Antiproliferative Activities of Lipophililic Fluoroquinolones- Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines. Asian Pacific journal of cancer prevention : APJCP 23 (5) (2022)
Buchra Haj Hussein, Violet Kasabri, Yusuf Al-Hiari, Shereen Arabiyat, Balqis Ikhmais, Sundus Alalawi, Tariq Al-Qirim
Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds. Asian Pacific journal of cancer prevention : APJCP 23 (12) (2022)
Buchra Haj Hussein, Violet Kasabri, Yusuf Al-Hiari, Shereen Arabiyat, Balqis Ikhmais, Sundus Alalawi, Tariq Al-Qirim
Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds. Asian Pacific journal of cancer prevention : APJCP 23 (12) (2022)
Buchra Haj Hussein, Violet Kasabri, Yusuf Al-Hiari, Shereen Arabiyat, Balqis Ikhmais, Sundus Alalawi, Tariq Al-Qirim
Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds. Asian Pacific journal of cancer prevention : APJCP 23 (12) (2022)
Phuoc-Tan Diep, Mohammed Chaudry, Adam Dixon, Faisal Chaudry, Violet Kasabri
Oxytocin, the panacea for long-COVID? a review. Hormone molecular biology and clinical investigation 43 (3) (2022)
Buchra Haj Hussein, Violet Kasabri, Yusuf Al-Hiari, Shereen Arabiyat, Balqis Ikhmais, Sundus Alalawi, Tariq Al-Qirim
Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds. Asian Pacific journal of cancer prevention : APJCP 23 (12) (2022)
Mohammed Ameen Fouad Salih, Yusuf Al-Hiari, Violet Kasabri, Rula Darwish, Hamza Abumansour, Laurance Bourghli, Sundus Al Alawi, Rabab Albashiti
Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines. Asian Pacific journal of cancer prevention : APJCP 23 (7) (2022)
Abdelrahman Al-Nuaimi, Yusuf Al-Hiari, Violet Kasabri, Randa Haddadin, Noor Mamdooh, Sundus Alalawi, Sara Khaleel
A Novel Class of Functionalized Synthetic Fluoroquinolones with Dual Antiproliferative - Antimicrobial Capacities. Asian Pacific journal of cancer prevention : APJCP 22 (4) (2021)
Mthanna AlKhalil, Yusuf Al-Hiari, Violet Kasabri, Shereen Arabiyat, Muhammad Al-Zweiri, Noor Mamdooh, Ahmad D Telfah
Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds. Drug development research 81 (4) (2020)
Rawan AbuZayed, Nailya Bulatova, Violet Kasabri, Maysa Suyagh, Lana Halaseh, Sundus AlAlawi
Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes. Hormone molecular biology and clinical investigation 37 (3) (2019)
Govand Yaseen Saber, Violet Kasabri, Mohammad Issa Saleh, Maysa Suyagh, Lana Halaseh, Ruba Jaber, Hana Abu-Hassan, Sundos Alalawi
Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes. Hormone molecular biology and clinical investigation 38 (1) (2019)
Shereen Arabiyat, Violet Kasabri, Yusuf Al-Hiari, Ihab Al-Masri, Sundus Alalawi, Yasser Bustanji
Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones. Asian Pacific journal of cancer prevention : APJCP 20 (8) (2019)
Abeer Abu Horan, Abla Albsoul-Younes, Violet Kasabri, Maysa Suyagh, Lana Halaseh, Sundus AlAlawi
Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes. Hormone molecular biology and clinical investigation 37 (3) (2019)
N Alhourani, Violet Kasabri, Y Bustanji, R Abbassi, Mohammad Hudaib
Potential Antiproliferative Activity and Evaluation of Essential Oil Composition of the Aerial Parts of Tamarix aphylla (L.) H.Karst.: A Wild Grown Medicinal Plant in Jordan. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)
Rawan Mohammad Al Saudi, Violet Kasabri, Randa Naffa, Nailya Bulatova, Yasser Bustanji
Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetes. Therapeutic advances in endocrinology and metabolism 9 (10) (2018)
Violet Kasabri, Esraa Shawakri, Amal Akour, Randa Naffa, Nahla Khawaja, Ibrahim Al-Sarraf, Jameel Bzour
Cross-sectional correlates of increased IL-18 but reduced fetuin-A and oxytocin with adiposity and blood indices in metabolic syndrome patients with and without prediabetes. Therapeutic advances in endocrinology and metabolism 9 (12) (2018)
Ibrahim Abdul Kareem Al-Sarraf, Violet Kasabri, Amal Akour, Randa Naffa
Melatonin and cryptochrome 2 in metabolic syndrome patients with or without diabetes: a cross-sectional study. Hormone molecular biology and clinical investigation 35 (2) (2018)
Qutaiba Qusay Al-Heety, Violet Kasabri, Amal Akour, Randa Naffa, Samar Abu Rkhaya
Cross-sectional correlates of paraoxonase 1 and soluble intercellular adhesion molecule-1 in metabolic syndrome patients with and without diabetes. Therapeutic advances in endocrinology and metabolism 9 (10) (2018)
Musa Moh'd Waleed Al-Batsh, Abla Albsoul-Younes, Violet Kasabri, Maysa Suyagh, Sundos Alalawi, Nada Yasin
Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes. Hormone molecular biology and clinical investigation 36 (3) (2018)
Safa'a Ali Al-Qudah, Violet Kasabri, Mohammad Issa Saleh, Maysa Suyagh, Sundos AlAlawi, Nada Yasin
Cross-sectional correlates of nesfatin and lipopolysaccharide binding protein in metabolic syndrome patients with and without prediabetes. Hormone molecular biology and clinical investigation 36 (3) (2018)
Noor Mamdooh, Violet Kasabri, Yusuf Al-Hiari, Ihab Almasri, Sundus Al-Alawi, Yasser Bustanji
Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compounds. Drug development research 80 (3) (2018)
Reem Sami Alquoqa, Violet Kasabri, Randa Naffa, Amal Akour, Yasser Bustanji
Cross-sectional correlates of myeloperoxidase and alpha-1-acid glycoprotein with adiposity, atherogenic and hematological indices in metabolic syndrome patients with or without diabetes. Therapeutic advances in endocrinology and metabolism 9 (9) (2018)
Razan Adnan Batta, Violet Kasabri, Amal Akour, Dana Hyassat, Abla Albsoul-Younes
Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan. International journal of clinical pharmacy 40 (1) (2017)